Circulating uveal melanoma cells: Should we test for them?;Devrait-on faire un test de détection des cellules métastatiques circulantes du mélanome de l'uvée?

Canadian Journal of Ophthalmology

Volumn 43, Issue 2, 2008, Pages 155-158

  Fernandes, Bruno F ^a   Belfort, Rubens N ^a   Di Cesare, Sebastian ^a   Burnier Jr , Miguel N ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MELAN A; MONOPHENOL MONOOXYGENASE;

CANCER CELL; CANCER GROWTH; CANCER RELAPSE; CANCER THERAPY; EDITORIAL; GENE EXPRESSION PROFILING; HUMAN; METASTASIS; POLYMERASE CHAIN REACTION; PROGNOSIS; TUMOR VOLUME; UVEA MELANOMA;

EID: 42049099030     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.3129/I08-011     Document Type: Editorial

References (17)

1. Shields JA, Shields CL, Donoso LA. Management of posterior uveal melanoma. Surv Ophthalmol 1991;36:161-95.
2. Fernandes BF, Odashiro AN, Saraiva VS, Logan P, Antecka E, Burnier MN Jr. Immunohistochemical expression of melan-A and tyrosinase in uveal melanoma. J Carcinog 2007;6:6.
3. Tobal K, Sherman LS, Foss AJ, Lightman SL. Detection of melanocytes from uveal melanoma in peripheral blood using the polymerase chain reaction. Invest Ophthalmol Vis Sci 1993;34:2622-5.
4. Boldin I, Langmann G, Richtig E, et al. Five-year results of prognostic value of tyrosinase in peripheral blood of uveal melanoma patients. Melanoma Res 2005;15:503-7.
5. Keilholz U, Goldin-Lang P, Bechrakis NE, et al. Quantitative detection of circulating tumor cells in cutaneous and ocular melanoma and quality assessment by real-time reverse transcriptase-polymerase chain reaction. Clin Cancer Res 2004;10:1605-12.
6. Schuster R, Bechrakis NE, Stroux A, et al. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma. Clin Cancer Res 2007;13:1171-8.
7. Callejo SA, Antecka E, Blanco PL, Edelstein C, Burnier MN. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study. Eye 2007;21:752-9.
8. Eskelin S, Pyrhönen S, Summanen P, Hahka-Kemppinen M, Kivelä T. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology 2000;107:1443-9.
9. Demicheli R, Terenziani M, Valagussa P, Moliterni A, Zambetti M, Bonadonna G. Local recurrences following mastectomy: support for the concept of tumor dormancy. J Natl Cancer Inst 1994;86:45-8.
10. Marshall J-CA, Nantel A, Blanco PL, Ash J, Cruess SA, Acheson E, et al. Transcriptional profiling of the evolution of uveal melanoma from cell lines to intraocular tumors to metastasis. Invest Ophthalmol Vis Sci 2005;46:3390 [Abstract].
11. Fidler IJ. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003;3:453-8.
12. Fidler IJ, Kripke ML. Metastasis results from preexisting variant cells within a malignant tumor. Science 1977;197:893-5.
13. Onken MD, Worley LA, Ehlers JP, Harbour JW. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 2004;64:7205-9.
14. Blanco PL, Marshall JC, Antecka E, et al. Characterization of ocular and metastatic uveal melanoma in an animal model. Invest Ophthalmol Vis Sci 2005;46:4376-82.
15. Marshall JC, Nantel A, Blanco P, Ash J, Cruess SR, Burnier MN Jr. Transcriptional profiling of human uveal melanoma from cell lines to intraocular tumors to metastasis. Clin Exp Metastasis 2007;24:353-62.
16. Dittmar T, Heyder C, Gloria-Maercker E, Hatzmann W, Zänker KS. Adhesion molecules and chemokines: the navigation system for circulating tumor (stem) cells to metastasize in an organ-specific manner. Clin Exp Metastasis 2007 Sept 8 [Epub ahead of print].
17. Harbour JW. Molecular prognostic testing in uveal melanoma: has it finally come of age? Arch Ophthalmol 2007;125:1122-3.